New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
Influenza A viral (IAV) fusion peptides are known for their important role in viral-cell fusion process and membrane destabilization potential which are compatible with those of antimicrobial peptides. Thus, by replacing the negatively or neutrally charged residues of FPs with positively charged lys...
Main Authors: | Wenjiao Wu, Dongguo Lin, Xintian Shen, Fangfang Li, Yuxin Fang, Kaiqun Li, Tianrong Xun, Guang Yang, Jie Yang, Shuwen Liu, Jian He |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4575187?pdf=render |
Similar Items
-
Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
by: Shuwen Liu, et al.
Published: (2013-01-01) -
Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry
by: Wenjiao Wu, et al.
Published: (2015-12-01) -
Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate.
by: Aaron G Schmidt, et al.
Published: (2010-04-01) -
Cathelicidin peptide analogues inhibit EV71 infection through blocking viral entry and uncoating.
by: Tingting Fan, et al.
Published: (2024-01-01) -
Membrane cholesterol regulates the oligomerization and fusogenicity of SARS-CoV fusion peptide: implications in viral entry
by: Meher, Geetanjali, et al.
Published: (2023)